ARTICLE | Company News
Takeda to acquire LigoCyte
October 5, 2012 1:00 AM UTC
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will acquire LigoCyte Pharmaceuticals Inc. (Bozeman, Mont.) for $60 million up front, plus potential milestones. LigoCyte's lead product is a norovirus VLP ...